[1] 国际肝胆胰学会中国分会, 中华医学会外科学分会肝脏外科学组.胆管癌诊断与治疗:外科专家共识[J].中国实用外科杂志, 2014, 34(1):1-5.
[2] Rizvi S, Gores GJ.Pathogenesis, diagnosis, and management of cholangiocarcinoma[J].Gastroenterology, 2013, 145(6):1215-1229.DOI:10.1053/j.gastro.2013.10.013.
[3] Isomoto H.Epigenetic alterations associated with cholangio-carcinoma (review)[J].Oncol Rep, 2009, 22(2):227-232.
[4] 王兴国.肝门胆管癌的外科手术治疗[J].中华肿瘤防治杂志, 2010, 17(20):1681-1682. DOI:10.16073/j.cnki.cjcpt.2010.20.021.
[5] Valle J, Wasan H, Palmer DH, et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[J].N Engl J Med, 2010, 362(14):1273-1281.DOI:10.1056/NEJMoa0908721.
[6] George J, Patel T.Noncoding RNA as therapeutic targets for hepatocellular carcinoma[J].Semin Liver Dis, 2015, 35(1):63-74.DOI:10.1055/s-0034-1397350.
[7] Lu TX, Rothenberg ME.MicroRNA[J].J Allergy Clin Immunol, 2018, 141(4):1202-1207.DOI:10.1016/j.jaci.2017.08.034.
[8] Bushati N, Cohen SM. microRNA functions[J]. Annu Rev Cell Dev Biol, 2007, 23:175-205.DOI:10.1146/annurev.cellbio.23.090506.123406.
[9] Meng FY, Henson R, Lang M, et al.Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines[J].Gastroenterology, 2006, 130(7):2113-2129.DOI:10.1053/j.gastro.2006.02.057.
[10] Lu L, Byrnes K, Han C, et al.miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth[J].Mol Cancer Res, 2014, 12(6):890-900. DOI:10.1158/1541-7786.MCR-13-0419.
[11] Wang LJ, He CC, Sui X, et al.MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN[J].Oncotarget, 2015, 6(8):5932-5946.DOI:10.18632/oncotarget.3465.
[12] Mott JL, Kobayashi S, Bronk SF, et al.Mir-29 regulates Mcl-1 protein expression and apoptosis[J].Oncogene, 2007, 26(42):6133-6140.DOI:10.1038/sj.onc.1210436.
[13] Zhang J, Han C, Wu T.MicroRNA-26a promotes cholangiocar-cinoma growth by activating β-catenin[J].Gastroenterology, 2012, 143(1):246-56.e8. DOI:10.1053/j.gastro.2012.03.045.
[14] Wang LJ, Zhang KL, Zhang N, et al.Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma[J].Oncotarget, 2015, 6(21):18631-18640. DOI:10.18632/oncotarget.4072.
[15] An FM, Yamanaka S, Allen S, et al.Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch[J].PLoS One, 2012, 7(10):e45606. DOI:10.1371/journal.pone.0045606.
[16] Meng F, Wehbe-Janek H, Henson R, et al.Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes[J].Oncogene, 2008, 27(3):378-386. DOI:10.1038/sj.onc.1210648.
[17] Meng FY, Henson R, Wehbe-Janek H, et al.The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes[J].J Biol Chem, 2007, 282(11):8256-8264.DOI:10.1074/jbc.M607712200.
[18] Peng F, Jiang J, Yu Y, et al.Direct targeting of SUZ12/ROCK₂ by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis[J].Br J Cancer, 2013, 109(12):3092-3104. DOI:10.1038/bjc.2013.655.
[19] Okamoto K, Miyoshi K, Murawaki Y.miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells[J].PLoS One, 2013, 8(10):e77623.DOI:10.1371/journal.pone.0077623.
[20] Shen L, Chen GP, Xia QF, et al.Exosomal miR-200 family as serum biomarkers for early detection and prognostic prediction of cholangiocarcinoma[J].Int J Clin Exp Pathol, 2019, 12(10):3870-3876.
[21] Han HS, Kim MJ, Han JH, et al.Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma[J].Hepatobiliary Pancreat Dis Int, 2020, 19(1):41-50. DOI:10.1016/j.hbpd.2019.10.009.
[22] Li L, Piontek K, Ishida M, et al.Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model[J].Hepatology, 2017, 65(2):501-514. DOI:10.1002/hep.28735.
[23] Gupta RA, Shah N, Wang KC, et al.Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J].Nature, 2010, 464(7291):1071-1076. DOI:10.1038/nature08975.
[24] Wang KC, Chang HY.Molecular mechanisms of long noncoding RNAs[J].Mol Cell, 2011, 43(6):904-914. DOI:10.1016/j.molcel.2011.08.018.
[25] Bhan A, Soleimani M, Mandal SS.Long noncoding RNA and cancer:a new paradigm[J].Cancer Res, 2017, 77(15):3965-3981.DOI:10.1158/0008-5472.can-16-2634.
[26] Ma SL, Li AJ, Hu ZY, et al.Co-expression of the carbamoyl-phosphate synthase 1 gene and its long non-coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma[J].Mol Med Rep, 2015, 12(6):7915-7926.DOI:10.3892/mmr.2015.4435.
[27] Jiang XM, Li ZL, Li JL, et al.LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma[J].Eur Rev Med Pharmacol Sci, 2017, 21(6):1242-1247.
[28] Zhang SH, Xiao JH, Chai Y, et al.LncRNA-CCAT1 promotes migration, invasion, and EMT in intrahepatic cholangiocar-cinoma through suppressing miR-152[J].Dig Dis Sci, 2017, 62(11):3050-3058.DOI:10.1007/s10620-017-4759-8.
[29] Xu Y, Wang ZD, Jiang XM, et al.Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition[J].Biomed Pharmacother, 2017, 92:17-23. DOI:10.1016/j.biopha.2017.05.061.
[30] Wang WT, Ye H, Wei PP, et al.LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner[J].J Hematol Oncol, 2016, 9(1):117. DOI:10.1186/s13045-016-0348-0.
[31] Zhang C, Li JY, Tian FZ, et al.Long noncoding RNA NEAT1 promotes growth and metastasis of cholangiocarcinoma cells[J].Oncol Res, 2018, 26(6):879-888. DOI:10.3727/096504017X15024935181289.
[32] 吕波, 朱新锋, 蔡常春, 等.长链非编码RNA CBR3-AS1在胆管癌中的表达及其临床意义[J].中国普通外科杂志, 2020, 28(8):960-966.DOI:10.7659/j.issn.1005-6947.2019.08.008.
[33] 吴大平, 徐璐, 吴焕良, 等.长链非编码RNA PVT1和miR-30 d-5 p在肝内胆管癌组织中的表达及其与预后相关性分析[J].现代肿瘤医学, 2020, 28(16):2833-2837. DOI:10.3969/j.issn.1672-4992.2020.16.021.
[34] Wang C, Mao ZP, Wang L, et al.Long non-coding RNA MALAT1 promotes cholangiocarcinoma cell proliferation and invasion by activating PI3K/Akt pathway[J].Neoplasma, 2017, 64(5):725-731.DOI:10.4149/neo_2017_510.
[35] Tan XY, Huang ZG, Li XG.Long non-coding RNA MALAT1 interacts with miR-204 to modulate human hilar cholangiocar-cinoma proliferation, migration, and invasion by targeting CXCR4[J].J Cell Biochem, 2017, 118(11):3643-3653. DOI:10.1002/jcb.25862.
[36] Sanger HL, Klotz G, Riesner D, et al.Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures[J].Proc Natl Acad Sci USA, 1976, 73(11):3852-3856. DOI:10.1073/pnas.73.11.3852.
[37] Zhang Y, Zhang XO, Chen T, et al.Circular intronic long noncoding RNAs[J].Mol Cell, 2013, 51(6):792-806. DOI:10.1016/j.molcel.2013.08.017.
[38] Xu Y, Yao Y, Zhong XY, et al.Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells[J].Biochem Biophys Res Commun, 2018, 496(2):455-461. DOI:10.1016/j.bbrc.2018.01.077.
[39] Xu Y, Yao Y, Liu YP, et al.Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma[J].Aging (Albany NY), 2019, 11(7):1907-1917. DOI:10.18632/aging.101872.
[40] Louis C, Desoteux M, Coulouarn C.Exosomal circRNAs:new players in the field of cholangiocarcinoma[J].Clin Sci (Lond), 2019, 133(21):2239-2244.DOI:10.1042/CS20190940.
[41] Lu Q, Fang T.Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma[J].J Clin Lab Anal, 2020, 34(4):e23138. DOI:10.1002/jcla.23138.
[42] Jiang XM, Li ZL, Li JL, et al.A novel prognostic biomarker for cholangiocarcinoma:circRNA Cdr1as[J].Eur Rev Med Pharmacol Sci, 2018, 22(2):365-371. DOI:10.26355/eurrev_201801_14182.
[43] Xu Y, Leng KM, Yao Y, et al.A novel circular RNA, circ-CCAC1, contributes to CCA progression, induces angiogenesis, and disrupts vascular endothelial barriers[J].Hepatology, 2020.DOI:10.1002/hep.31493.
[44] Han YN, Li Y, Xia SQ, et al.PIWI proteins and PIWI-interacting RNA:emerging roles in cancer[J].Cell Physiol Biochem, 2017, 44(1):1-20.DOI:10.1159/000484541.
[45] Gu XJ, Wang C, Deng H, et al.Exosomal PiRNA profiling revealed unique circulating PiRNA signatures of cholangioca-rcinoma and gallbladder carcinoma[J].Acta Biochim Biophys Sin (Shanghai), 2020, 52(5):475-484. DOI:10.1093/abbs/gmaa028.
[46] 温松奇, 熊小凡, 杨光耀, 等.PIWIL2蛋白在肝门部胆管癌组织和细胞株中的表达及临床意义[J].中华肝胆外科杂志, 2014, 20(4):280-283. DOI:10.3760/cma.j.issn.1007-8118.2014.04.012.